1. Alvogen's clindamycin product recalled in US

   News item 01 July 2017 Pages: 1 - 1

2. Ibrutinib-induced pneumonitis: UMC confirms signal

   News item 01 July 2017 Pages: 2 - 2

3. Insufficient evidence of Tecfidera-induced kidney injury

   News item 01 July 2017 Pages: 3 - 3

4. Launch of pilot WHO mobile app

   News item 01 July 2017 Pages: 4 - 4

5. Risk of heart failure with DPP-4 inhibitors

   News item 01 July 2017 Pages: 5 - 5

6. Selexipag contraindicated with strong CYP2C8 inhibitors

   Correspondence 01 July 2017 Pages: 6 - 6

7. SGLT2 inhibitor-related genital pruritus: impact on QoL?

   News item 01 July 2017 Pages: 7 - 7

8. Shortages of sodium bicarbonate injections in US, Canada

   News item 01 July 2017 Pages: 8 - 8

9. Visual colour distortions with pregabalin

   News item 01 July 2017 Pages: 9 - 9

10. Association between statins and Parkinson's disease

    Clinical study 01 July 2017 Pages: 10 - 10

11. Liraglutide associated with acute pancreatitis?

    Clinical study 01 July 2017 Pages: 11 - 11

12. Surveillance for drug-drug and drug-herb interactions

    Clinical study 01 July 2017 Pages: 12 - 12

13. Acenocoumarol

    Case report 01 July 2017 Pages: 13 - 13

14. Acetazolamide

    Case report 01 July 2017 Pages: 14 - 14

15. Acetylcysteine/mecobalamin/methylfolate

    Case report 01 July 2017 Pages: 15 - 15

16. Aciclovir

    Case report 01 July 2017 Pages: 16 - 16

17. Aciclovir/valaciclovir

    Case report 01 July 2017 Pages: 17 - 17

18. Acitretin

    Case report 01 July 2017 Pages: 18 - 18

19. Acitretin

    Case report 01 July 2017 Pages: 19 - 19

20. Adalimumab

    Case report 01 July 2017 Pages: 20 - 20

21. Adalimumab

    Case report 01 July 2017 Pages: 21 - 21

22. Adalimumab/immune-globulin interaction

    Case report 01 July 2017 Pages: 22 - 22

23. Adefovir

    Case report 01 July 2017 Pages: 23 - 23

24. Afatinib

    Case report 01 July 2017 Pages: 24 - 24

25. Afatinib

    Case report 01 July 2017 Pages: 25 - 25

26. Aflibercept/ranibizumab

    Case report 01 July 2017 Pages: 26 - 26

27. Alcohol

    Case report 01 July 2017 Pages: 27 - 27

28. Alcohol/bleomycin

    Case report 01 July 2017 Pages: 28 - 28

29. Alemtuzumab

    Case report 01 July 2017 Pages: 29 - 29

30. Alemtuzumab

    Case report 01 July 2017 Pages: 30 - 30

31. Alemtuzumab

    Case report 01 July 2017 Pages: 31 - 31

32. Alendronic acid

    Case report 01 July 2017 Pages: 32 - 32

33. Alfacalcidol

    Case report 01 July 2017 Pages: 33 - 33

34. Alimemazine/desloratadine/fexofenadine/loratadine

    Case report 01 July 2017 Pages: 34 - 34

35. Allopurinol

    Case report 01 July 2017 Pages: 35 - 35

36. Alteplase

    Case report 01 July 2017 Pages: 36 - 36

37. Ambroxol

    Case report 01 July 2017 Pages: 37 - 37

38. Amiodarone

    Case report 01 July 2017 Pages: 38 - 38

39. Amiodarone

    Case report 01 July 2017 Pages: 39 - 39

40. Amitriptyline/cyclobenzaprine overdose

    Case report 01 July 2017 Pages: 40 - 40

41. Amlodipine

    Case report 01 July 2017 Pages: 41 - 41

42. Antibacterials

    Case report 01 July 2017 Pages: 42 - 42

43. Antineoplastics

    Case report 01 July 2017 Pages: 43 - 43

44. Antineoplastics

    Case report 01 July 2017 Pages: 44 - 44

45. Antineoplastics

    Case report 01 July 2017 Pages: 45 - 45

46. Antipsychotics

    Case report 01 July 2017 Pages: 46 - 46

47. Antithymocyte globulin/eculizumab/prednisone/tacrolimus

    Case report 01 July 2017 Pages: 47 - 47

48. Apixaban/rivaroxaban

    Case report 01 July 2017 Pages: 48 - 48

49. Apixaban/rivaroxaban

    Case report 01 July 2017 Pages: 49 - 49

50. Argatroban/cilostazol/clopidogrel

    Case report 01 July 2017 Pages: 50 - 50